Kalytera Therapeutics, Inc. engages in the development of next generation cannabinoid therapeutics. It also offers development programs for bon fracture healing; osteogenesis imperfecta; osteoporosis; and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan on October 15, 2004 and is headquartered in San Rafael, CA.
No Data
No Data